TRANSFORMATIVE MEDICINES
FOR CHRONIC AUTOIMMUNE
AND INFLAMMATORY DISEASES

Mission


Legacy Healthcare is developing transformative medicines for the treatment of autoimmune and inflammatory diseases, with an immune-sparing mode of action, allowing safe chronic use.

Our first drug, Coacillium, achieves this goal.

Coacillium cutaneous solution has been filed for approval with EMA for the treatment of alopecia areata, a debilitating autoimmune dermatological disease with intense psychological impact on all patients, especially in children.